SURVIVE is not a good acronym for a trial of inotropic drugs in decompensated heart failure: if there is one certainty in cardiac pharmacology, it is that inotropic drugs never improve survival. They usually have the opposite effect. This was a large trial of patients who “required inotropic support
JAMA 2 May 2007 Vol 297
